GLORIA

GEOMAR Library Ocean Research Information Access

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
Filter
  • Boisserie, Gilbert  (2)
  • Medizin  (2)
Materialart
Sprache
Erscheinungszeitraum
Fachgebiete(RVK)
  • Medizin  (2)
RVK
  • 1
    Online-Ressource
    Online-Ressource
    Wiley ; 2005
    In:  International Journal of Cancer Vol. 116, No. 6 ( 2005-10-10), p. 992-997
    In: International Journal of Cancer, Wiley, Vol. 116, No. 6 ( 2005-10-10), p. 992-997
    Kurzfassung: Oligodeoxynucleotides containing CpG motifs (CpG‐ODN) display broad immunostimulating activity and are currently under clinical trial in various malignancies, including recurrent glioblastomas. Combining CpG‐ODN with another therapy that could induce antigen release might enhance tumor‐specific immune response. We investigated whether radiotherapy (RT) could be associated advantageously to intratumoral injections of CpG‐ODN. Fisher rats bearing 9L glioma were treated with various combinations of RT and CpG‐28, an oligonucleotide with good immunostimulating activity. RT and CpG‐28 induced complete tumor remission in one‐third of the animals. When both treatments were combined, complete tumor remission was achieved in two‐thirds of the animals ( p 〈 0.001 when compared to non‐treated rats, p 〈 0.03 when compared to CpG‐28 alone). Such efficacy was not observed in nude mice, underlying the role of T cells in antitumor effects. The combination of both treatments appeared optimal when the delay between RT and CpG‐28 administration was 〈 3 days (from 100% survival for a 3 days delay, to 57% survival for a 21 days delay, p 〈 0.05). Tumor infiltration by immune cells and expression within tumors of the CpG receptor, TLR9, were not modified by irradiation. These results support an attractive strategy of sequential radiotherapy and immunotherapy by CpG‐ODN and have potential implications for future clinical trials with CpG‐ODN. © 2005 Wiley‐Liss, Inc.
    Materialart: Online-Ressource
    ISSN: 0020-7136 , 1097-0215
    URL: Issue
    RVK:
    Sprache: Englisch
    Verlag: Wiley
    Publikationsdatum: 2005
    ZDB Id: 218257-9
    ZDB Id: 1474822-8
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    Online-Ressource
    Online-Ressource
    Ovid Technologies (Wolters Kluwer Health) ; 2004
    In:  Neurosurgery Vol. 55, No. 6 ( 2004-12-01), p. 1252-1262
    In: Neurosurgery, Ovid Technologies (Wolters Kluwer Health), Vol. 55, No. 6 ( 2004-12-01), p. 1252-1262
    Kurzfassung: To define prognostic factors for local control and survival in 90 consecutive patients treated by fractionated photon and proton radiation for chordoma or chondrosarcoma of the cranial base and upper cervical spine. METHODS: Between December 1995 and December 2000, 90 patients (median age, 51.3 yr; range, 10–85 yr; male/female ratio, 3:2) were treated by a combination of high-energy photons and protons. Sixty-four patients had a chordoma, and 26 had a chondrosarcoma. The proton component was delivered by the 201-MeV proton beam of the Centre de Protonthérapie d'Orsay. The median total dose delivered to the gross tumor volume (GTV) was 67 cobalt Gray equivalents (range, 22–70 cobalt Gray equivalents). RESULTS: With a median follow-up of 34 months (range, 3–74 mo), treatment of 25 tumors failed locally. The 3-year local control rates were 69.2% (±6.0%) and 91.6% (±8.4%) for chordomas and chondrosarcomas, respectively. According to multivariate analysis, a small tumor volume excluded from the 95% isodose line (P = 0.032; relative risk [RR], 0.098; 95% confidence interval [CI] , 0.01–0.81) and a controlled tumor (P = 0.049; RR, 0.19; 95% CI, 0.04–0.99) were independent favorable prognostic factors for overall survival. On multivariate analysis, a high minimum dose (P = 0.02; RR, 2.8; 95% CI, 1.2–6.6), a high tumor control probability (P = 0.02; RR, 3.8; 95% CI, 1.2–12.5), a high dose delivered to 95% of the GTV (P = 0.03; RR, 3.4; 95% CI, 1.15–10.2), a high GTV encompassed by the 90% isodose line (P = 0.01; RR, 3.29; 95% CI, 1.29–8.44), and a small GTV excluded from the 90% isodose line (P = 0.036; RR, 0.4; 95% CI, 0.1–0.9) were independent favorable prognostic factors for local control. CONCLUSION: In chordomas and chondrosarcomas of the cranial base and cervical spine treated by surgical resection and then by high-dose photon and proton irradiation, local control is mainly dependent on the quality of radiation, especially dose uniformity within the GTV. Special attention must be paid to minimize underdosed areas because of the close proximity of critical structures and to redefine and possibly escalate dose constraints to tumor targets in future studies in view of the low toxicity observed to date.
    Materialart: Online-Ressource
    ISSN: 0148-396X , 1524-4040
    RVK:
    Sprache: Englisch
    Verlag: Ovid Technologies (Wolters Kluwer Health)
    Publikationsdatum: 2004
    ZDB Id: 1491894-8
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...